IP and devolution questions raised as Genetic Technology (Precision Breeding) Bill begins its Parliamentary process

Companies involved in developing cell and gene therapies face challenges in recruiting skilled talent fast enough to keep pace with

Life Sciences analysis: Peter Rudd-Clarke, partner, and Anna Lundy, associate director, at Osborne Clarke discuss how the medical device industry

Reworked guidance reflects the evolution in models for healthcare service delivery, especially with regard to technological innovation

Significant changes to the patent landscape across Europe are coming, what can be expected and what can be done to

While we await detailed legislation, companies intending to place medical devices on the UK market can begin to prepare for

This infographic highlights some of the key overall findings and sector figures from our detailed report produced in partnership with

This detailed report, produced in partnership with European Company Lawyers Association (ECLA), explores the challenges and opportunities associated with new

Opportunities are available for those that navigate the regulatory system and provide evidence of their products' efficacy and performance

As the economy falters and NHS waiting lists grow, 2021 legislation offers wide powers to reform product rules and spur

The Genetic Technology (Precision Breeding) Bill seeks to simplify the regulatory regime for precision-bred plants and animals

A new vaccine IP waiver proposal has been published by the WTO Director-General following informal negotiations between the EU, India